Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3507870017 | Ruxolitinib phosphate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3507871018 | Ruxolitinib phosphate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4063751000052119 | ruxolitinibfosfat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ruxolitinib phosphate (substance) | Is a | Ruxolitinib | false | Inferred relationship | Some | ||
| Ruxolitinib phosphate (substance) | Has disposition (attribute) | Janus kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Ruxolitinib phosphate (substance) | Is modification of (attribute) | Ruxolitinib | true | Inferred relationship | Some | ||
| Ruxolitinib phosphate (substance) | Is a | Nitrile (substance) | true | Inferred relationship | Some | ||
| Ruxolitinib phosphate (substance) | Is a | Janus kinase inhibitor | true | Inferred relationship | Some | ||
| Ruxolitinib phosphate (substance) | Is a | Pyrazole derivative | true | Inferred relationship | Some | ||
| Ruxolitinib phosphate (substance) | Is a | Enzyme inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Ruxolitinib phosphate (substance) | Inferred relationship | Some | 1 |
| Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet | Has precise active ingredient | True | Ruxolitinib phosphate (substance) | Inferred relationship | Some | 1 |
| Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet | Has precise active ingredient | True | Ruxolitinib phosphate (substance) | Inferred relationship | Some | 1 |
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Ruxolitinib phosphate (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR